Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)
Clinical trial NCT05085977 · COMPLETED
Trial details
- NCT number
- NCT05085977
- Sponsor
- Protara Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-10
- Primary completion
- 2024-09-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.